On Jan. 2, 1996, Stanford Medicine researchers announced they had discovered that the p53 protein, known to be involved in controlling cancerous tumors, works as an ’emergency brake’ on cancer development.

p53 is a crucial tumour suppressor that responds to diverse stress signals by orchestrating specific cellular responses, including transient cell cycle arrest, cellular senescence and apoptosis, which are all processes associated with tumour suppression.